Ancillary study of the adoption and sustainability of ED-initiated buprenorphine (CTN-0079-a-1). DSC5 contract. 09/20/2019 - 02/28/2021. N01DA-19-2250.
Ended Awarded Last action
- Contract number
- 75N95019F00089
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $789,585
Award facts
- Opportunity
-
- 75N95019R00016 Solicitation number
- Contract value 100% obligated
- $789,585.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $237,062 | |
| Original award | $552,523 |
About this award
The National Institute on Drug Abuse awarded a $789,585 cost-plus-fixed-fee delivery order contract to The Emmes Company LLC under its Data, Statistics, and Clinical Trial Support Center indefinite delivery/indefinite quantity contract vehicle. The delivery order is to conduct an ancillary study of the adoption and sustainability of buprenorphine initiated through emergency departments, supporting NIDA's mission to advance science on the causes and consequences of drug use and addiction. Performance will take place in Potomac, Maryland over a three year period concluding in July 2022. No subcontractors or additional details were provided in the award information.
Quick answers
Who was awarded contract 75N95019F00089?
75N95019F00089 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 20, 2019.
How much is contract 75N95019F00089 worth?
The government has obligated $789,585 on 75N95019F00089.
Is contract 75N95019F00089 an order under another contract?
Yes. 75N95019F00089 is a delivery order under 75N95019D00013, an indefinite delivery contract.
Was contract 75N95019F00089 competed?
The extent of competition for 75N95019F00089 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award